Developments in the field of technology, healthcare, and living conditions have significantly improved the living conditions ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Researchers conducted a cross-sectional analysis to evaluate bone health among menopausal women in Zimbabwe with and without human immunodeficiency virus.

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Dispatch and carefully placed it inside my copy of And The Band Played On: Politics, People, and the AIDS Epidemic – his most ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...

The Chhattisgarh transport department is reviewing a revised bus fare proposal, ensuring compliance with a high court order regarding fare exemptions for vulnerable groups. Passes and information ...

Leerink upgraded Gilead (GILD) to Outperform from Market Perform with a price target of $96, up from $74. The stock has appreciated following ...

Gilead and Merck said their once-weekly pill to treat HIV resulted in a comparable level of viral suppression compared to a ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

As the song goes, Debbie with a D and London Manchester looked like Taylor Swift in the light of the AllWays Lounge in New ...